Arachidonic acid protects neonatal rat cardiac myocytes from ischaemic injury through epsilon protein kinase C.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 11282079)

Published in Cardiovasc Res on April 01, 2001

Authors

K Mackay1, D Mochly-Rosen

Author Affiliations

1: Department of Molecular Pharmacology, Stanford University School of Medicine, 269 Campus Drive, CCSR 3145, Stanford, CA 94305-5332, USA.

Articles by these authors

Cloning of an intracellular receptor for protein kinase C: a homolog of the beta subunit of G proteins. Proc Natl Acad Sci U S A (1994) 3.95

Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc Natl Acad Sci U S A (2001) 3.28

Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol (2000) 3.13

Sustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation. Proc Natl Acad Sci U S A (1999) 2.44

Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the epsilon isozyme of protein kinase C. J Neurosci (2000) 2.20

A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. J Biol Chem (1996) 2.16

A selective epsilon-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J Biol Chem (1997) 2.03

Adaptor proteins in protein kinase C-mediated signal transduction. Oncogene (2001) 1.99

C2 region-derived peptides inhibit translocation and function of beta protein kinase C in vivo. J Biol Chem (1995) 1.82

Localization of protein kinase C isozymes in cardiac myocytes. Exp Cell Res (1994) 1.82

The coatomer protein beta'-COP, a selective binding protein (RACK) for protein kinase Cepsilon. J Biol Chem (1997) 1.76

Evidence of zeta protein kinase C involvement in polymorphonuclear neutrophil integrin-dependent adhesion and chemotaxis. J Biol Chem (1998) 1.74

An autoregulatory region in protein kinase C: the pseudoanchoring site. Proc Natl Acad Sci U S A (1995) 1.67

Domain structure and phosphorylation of protein kinase C. J Biol Chem (1987) 1.65

Peptide modulators of protein-protein interactions in intracellular signaling. Nat Biotechnol (1998) 1.62

Molecular transporters for peptides: delivery of a cardioprotective epsilonPKC agonist peptide into cells and intact ischemic heart using a transport system, R(7). Chem Biol (2001) 1.58

Binding specificity for RACK1 resides in the V5 region of beta II protein kinase C. J Biol Chem (2001) 1.50

An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia. J Biol Chem (1999) 1.42

Protein kinase C directly phosphorylates the insulin receptor in vitro and reduces its protein-tyrosine kinase activity. Proc Natl Acad Sci U S A (1986) 1.40

Translocation inhibitors define specificity of protein kinase C isoenzymes in pancreatic beta-cells. J Biol Chem (1997) 1.40

Protein kinase C-epsilon is responsible for the protection of preconditioning in rabbit cardiomyocytes. J Mol Cell Cardiol (1999) 1.33

RACK1, a protein kinase C anchoring protein, coordinates the binding of activated protein kinase C and select pleckstrin homology domains in vitro. Biochemistry (1999) 1.27

Mitochondrial protein kinase Cepsilon (PKCepsilon): emerging role in cardiac protection from ischaemic damage. Biochem Soc Trans (2007) 1.24

Cardioprotection from ischemia by a brief exposure to physiological levels of ethanol: role of epsilon protein kinase C. Proc Natl Acad Sci U S A (1999) 1.23

Phorbol myristate acetate-mediated stimulation of transcytosis and apical recycling in MDCK cells. J Cell Biol (1994) 1.23

An improved permeabilization protocol for the introduction of peptides into cardiac myocytes. Application to protein kinase C research. Circ Res (1996) 1.17

The roles of PKCdelta and epsilon isoenzymes in the regulation of myocardial ischaemia/reperfusion injury. Biochem Soc Trans (2007) 1.17

Agonists and antagonists of protein kinase C function, derived from its binding proteins. J Biol Chem (1994) 1.14

Opposing effects of delta and xi PKC in ethanol-induced cardioprotection. J Mol Cell Cardiol (2001) 1.13

The HIV nef protein associates with protein kinase C theta. J Biol Chem (1996) 1.12

The product of the ataxia-telangiectasia group D complementing gene, ATDC, interacts with a protein kinase C substrate and inhibitor. Proc Natl Acad Sci U S A (1995) 1.10

Inhibition of the spontaneous rate of contraction of neonatal cardiac myocytes by protein kinase C isozymes. A putative role for the epsilon isozyme. Circ Res (1995) 1.09

Pharmacologic modulation of protein kinase C isozymes: the role of RACKs and subcellular localisation. Pharmacol Res (1999) 1.06

Comparison of S100b protein with calmodulin: interactions with melittin and microtubule-associated tau proteins and inhibition of phosphorylation of tau proteins by protein kinase C. Biochemistry (1987) 1.06

Evidence for functional role of epsilonPKC isozyme in the regulation of cardiac Ca(2+) channels. Am J Physiol Heart Circ Physiol (2000) 1.04

Signal transduction by the polymeric immunoglobulin receptor suggests a role in regulation of receptor transcytosis. J Cell Biol (1996) 1.04

Monoclonal anti-acetylcholine-receptor antibodies directed against the cholinergic binding site. Biochemistry (1981) 1.03

C2 region-derived peptides of beta-protein kinase C regulate cardiac Ca2+ channels. Circ Res (1997) 1.03

Localization, anchoring, and functions of protein kinase C isozymes in the heart. J Mol Cell Cardiol (2001) 1.02

Inhibition of protein kinase C function by injection of intracellular receptors for the enzyme. Biochem Biophys Res Commun (1992) 1.01

An inhibitory fragment derived from protein kinase Cepsilon prevents enhancement of nerve growth factor responses by ethanol and phorbol esters. J Biol Chem (1997) 1.01

Sustained inhibition of PKCα reduces intravasation and lung seeding during mammary tumor metastasis in an in vivo mouse model. Oncogene (2010) 1.00

Distinct cellular and regional localization of immunoreactive protein kinase C in rat brain. Proc Natl Acad Sci U S A (1987) 0.99

Activation of epsilon protein kinase C correlates with a cardioprotective effect of regular ethanol consumption. Proc Natl Acad Sci U S A (1998) 0.97

Interaction of monoclonal antibodies to Torpedo acetylcholine receptor with the receptor of skeletal muscle. Muscle Nerve (1983) 0.93

Distinct responses of protein kinase C isozymes to c-erbB-2 activation in SKBR-3 human breast carcinoma cells. Cell Growth Differ (1994) 0.93

Evidence for functional role of epsilonPKC isozyme in the regulation of cardiac Na(+) channels. Am J Physiol Cell Physiol (2001) 0.92

Involvement of protein kinase Cepsilon (PKCepsilon) in thyroid cell death. A truncated chimeric PKCepsilon cloned from a thyroid cancer cell line protects thyroid cells from apoptosis. J Biol Chem (1999) 0.91

Competitive inhibitors and allosteric activators of protein kinase C isoenzymes: a personal account and progress report on transferring academic discoveries to the clinic. Biochem Soc Trans (2007) 0.90

Exposure of HeLa DNA polymerase alpha to protein kinase C affects its catalytic properties. J Biol Chem (1987) 0.89

Monoclonal antibodies modify acetylcholine-induced ionic channel properties in cultured chick myoballs. J Membr Biol (1983) 0.89

The identification and purification of a mammalian-like protein kinase C in the yeast Saccharomyces cerevisiae. Proc Biol Sci (1991) 0.88

Phospholipase C-gamma 1 binding to intracellular receptors for activated protein kinase C. Proc Natl Acad Sci U S A (1994) 0.87

Proteins kinase Cɛ is required for non-small cell lung carcinoma growth and regulates the expression of apoptotic genes. Oncogene (2011) 0.87

Characterization of the binding and phosphorylation of cardiac calsequestrin by epsilon protein kinase C. FEBS Lett (1999) 0.86

The role of adenosine and adenosine transport in ethanol-induced cellular tolerance and dependence. Possible biologic and genetic markers of alcoholism. Ann N Y Acad Sci (1991) 0.86

DeltaPKC-mediated activation of epsilonPKC in ethanol-induced cardiac protection from ischemia. J Mol Cell Cardiol (2005) 0.83

Chronic ethanol-induced heterologous desensitization is mediated by changes in adenosine transport. Biochem Soc Symp (1990) 0.83

Stimulus-dependent subcellular localization of activated protein kinase C; a study with acidic fibroblast growth factor and transforming growth factor-beta 1 in cardiac myocytes. J Mol Cell Cardiol (1995) 0.82

Islet cell survival during isolation improved through protein kinase C epsilon activation. Transplant Proc (2008) 0.82

An anti-acetylcholine receptor monoclonal antibody cross-reacts with phosvitin. FEBS Lett (1983) 0.82

Antigenic specificity of acetylcholine receptor in developing muscle. Studies with monoclonal antibodies. J Neuroimmunol (1985) 0.81

Nicotinic acetylcholine receptor desensitization is regulated by activation-induced extracellular adenosine accumulation. J Neurosci (1992) 0.80

Acetylcholine receptor: molecular dissection and monoclonal antibodies in the study of experimental myasthenia. Ann N Y Acad Sci (1981) 0.79

Involvement of a p38 mitogen-activated protein kinase phosphatase in protecting neonatal rat cardiac myocytes from ischemia. J Mol Cell Cardiol (2000) 0.79

Differential activation of protein kinase C isozymes by phorbol ester and collagen in human skin microvascular endothelial cells. J Invest Dermatol (1996) 0.79

Developmental expression of protein kinase C subspecies in rat brain-pituitary axis. Mol Cell Endocrinol (1994) 0.77

Immune regulation of experimental myasthenia. J Neurol Neurosurg Psychiatry (1980) 0.75

Molecular genetic approaches. II. Expression-interaction cloning. Methods Mol Biol (1998) 0.75

Prolonged phorbol ester treatment down-regulates protein kinase C isozymes and increases contraction rate in neonatal cardiac myocytes. Life Sci (1995) 0.75

Modification of acetylcholine receptor: chemical and immunological characterization of polyalanyl acetylcholine receptor. FEBS Lett (1980) 0.75

Molecular aspects of experimental autoimmune myasthenia gravis. Prog Clin Biol Res (1981) 0.75